This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Aetna Study Shows Decrease In Prescription Drug Misuse, Waste And Abuse Through Increased Monitoring

Stocks in this article: AET

Prescription drug abuse is an epidemic in the United States with about 2.4 million Americans struggling with addiction to prescription painkillers known as opioids. According to the CDC, opioid addiction is a leading cause of death in the United States and adds $72.5 billion in expense to the health care system each year. 1 A recent study of Aetna’s (NYSE: AET) programs designed to address prescription drug misuse, waste and abuse showed reduced opioid use among 4.3 million members by 15 percent between January 2010 and January 2012. These outcomes were unveiled at the Pharmacy Benefit Management Institute’s Drug Benefit Conference held February 18 – 20 in Las Vegas.

“We’re encouraged by the evidence that our misuse, waste and abuse programs are controlling access to drugs with high potential for abuse,” said Yrena Friedmann, Pharm.D., Director, Aetna Pharmacy Management. “We’ll continue to do our part to fight prescription drug abuse. We must remain vigilant for the health and safety of our members.”

How Aetna’s Misuse, Waste and Abuse Prevention Programs Work

Aetna’s programs identify when a member is accessing a drug in an amount that may be unsafe and safeguards to stop potentially dangerous situations. Aetna pharmacists work with members to ensure they get only the drug needed, in the right amount.

Aetna’s misuse, waste and abuse prevention programs work together in four phases to ensure member safety and offer support to those who need it.

1. Control – Access to prescription drugs with high potential for abuse is controlled at the pharmacy by:

  • placing a limit on how much of a drug is covered at a given time,
  • verifying medical need before coverage of a drug is approved, and
  • advising the pharmacist if a drug’s dosage amount appears unsafe.

2. Find – Each member’s prescription drug history is reviewed before a new prescription is filled. This review allows patterns of frequent use or suspicious dispensing to be identified.

3. Help – Extra support is offered to members who may be using a prescription drug unsafely. This includes:

  • Referral to a pain specialist.
  • Encouragement to enroll in a pain management program.
  • Referral to Aetna Behavioral Health for emotional support.
  • Referral to Aetna Case Management for additional support.

4. Limit – Members who don’t respond to support when it’s offered may have limited access to their prescription drug benefits, such as:

  • Becoming restricted to only one health care provider.
  • Having reduced refill frequency and coverage.
  • Getting referred to appropriate state and federal agencies.

To learn more about how Aetna’s Pharmacy Management team is working to maintain member safety, visit


About Aetna

Aetna is one of the nation's leading diversified health care benefits companies, serving approximately 37.3 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities, Medicaid health care management services and health information technology services. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see

Copyright Business Wire 2010

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs